FDA approves fourth biosimilar in US

26-09-2016

FDA approves fourth biosimilar in US

Roman Sinichkin / Shutterstock.com

The US Food and Drug Administration (FDA) has approved a biosimilar application by pharmaceutical company Amgen, the fourth such product to be rubberstamped in the country.


biosimilar, FDA, Amgen, AbbVie, Amjevita, Humira, US Food and Drug Administration

LSIPR